Age-Related Alterations in Gait Function in Freely Moving Male C57BL/6 Mice: Translational Relevance of Decreased Cadence and Increased Gait Variability.


Journal

The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837

Informations de publication

Date de publication:
16 08 2019
Historique:
received: 05 07 2018
pubmed: 2 11 2018
medline: 12 6 2020
entrez: 2 11 2018
Statut: ppublish

Résumé

Age-related gait dysfunction and balance disorders are a major cause of falls and injury in the elderly population. Epidemiological studies have shown that disturbances in gait coordination which manifest with age are associated with increased morbidity and mortality, impaired cognitive capacity, as well as reduced level of function and loss of independence. In geroscience, mice are the most frequently used model system to test efficiency of antiaging interventions. Despite the clinical importance of age-related gait abnormalities in older adults, the impact of aging on mouse gait coordination is not well documented in the literature. To characterize the effect of aging on mouse gait, we assessed gait function in young (3-month-old) and aged (24-month-old) freely moving C57BL/6 mice using the semiautomated, highly sensitive CatWalk XT system for quantitative assessment of footfall and motor performance. We found that aged mice exhibited significantly decreased cadence and increased stride time variability. Aging also tended to alter footfall patterns. In aged mice, speed, swing speed, stride length, duty cycle, base of support, terminal dual stance, the regularity index, and the gait symmetry index were unaltered. Thus, aging is associated with characteristic alterations in gait function in C57BL/6 mice, which could potentially be assessed as clinically relevant endpoints in geroscience studies testing the effects of antiaging interventions.

Identifiants

pubmed: 30383221
pii: 5154747
doi: 10.1093/gerona/gly242
pmc: PMC6696715
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1417-1421

Subventions

Organisme : NIGMS NIH HHS
ID : U54 GM104938
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG052363
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG047879
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS085002
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM125528
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS100782
Pays : United States

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Rejuvenation Res. 2009 Jun;12(3):177-84
pubmed: 19594326
Adv Neurol. 2001;87:111-7
pubmed: 11347214
Neurosci Biobehav Rev. 2017 Mar;74(Pt A):149-162
pubmed: 28115194
J Am Geriatr Soc. 2006 Jun;54(6):991-1001
pubmed: 16776798
Aging Cell. 2017 Jun;16(3):469-479
pubmed: 28295976
Acta Bioeng Biomech. 2014;16(1):29-35
pubmed: 24708092
Am J Physiol Heart Circ Physiol. 2017 Jan 1;312(1):H1-H20
pubmed: 27793855
JAMA. 2011 Jan 5;305(1):50-8
pubmed: 21205966
Ann Neurol. 2011 Aug;70(2):213-20
pubmed: 21674588
Gait Posture. 2005 Feb;21(2):178-85
pubmed: 15639397
Age (Dordr). 2016 Aug;38(4):363-375
pubmed: 27488838
Neuroepidemiology. 2007;29(3-4):193-200
pubmed: 18043004
Geroscience. 2017 Feb;39(1):33-42
pubmed: 28299642
J Gerontol A Biol Sci Med Sci. 2014 Dec;69(12):1485-91
pubmed: 24336799
J Gerontol A Biol Sci Med Sci. 2013 Aug;68(8):929-37
pubmed: 23250002
J Geriatr Oncol. 2015 Nov;6(6):484-96
pubmed: 26362356
J Gerontol A Biol Sci Med Sci. 2015 Dec;70(12):1526-32
pubmed: 26386013
J Neurol. 2010 Mar;257(3):392-8
pubmed: 19784714
J Gerontol A Biol Sci Med Sci. 2005 May;60(5):627-32
pubmed: 15972616
Geroscience. 2017 Dec;39(5-6):601-614
pubmed: 29243191
J Gerontol A Biol Sci Med Sci. 2012 Mar;67(3):217-27
pubmed: 22021390
Neurology. 2010 May 18;74(20):1627-33
pubmed: 20479362
Gait Posture. 2013 Apr;37(4):500-5
pubmed: 23018028
Gait Posture. 2014;40(1):225-30
pubmed: 24792638
J Gerontol A Biol Sci Med Sci. 2016 Apr;71(4):427-30
pubmed: 26297941
Aging Cell. 2018 Apr;17(2):
pubmed: 29405550
Gait Posture. 2018 Mar;61:346-352
pubmed: 29428714

Auteurs

Stefano Tarantini (S)

Vascular Cognitive Impairment and Neurodegeneration Program, Center for Geroscience, University of Oklahoma Health Sciences Center.
Translational Geroscience Laboratory, Reynolds Oklahoma Center on Aging, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center.

Andriy Yabluchanskiy (A)

Vascular Cognitive Impairment and Neurodegeneration Program, Center for Geroscience, University of Oklahoma Health Sciences Center.
Translational Geroscience Laboratory, Reynolds Oklahoma Center on Aging, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center.

Gábor A Fülöp (GA)

Vascular Cognitive Impairment and Neurodegeneration Program, Center for Geroscience, University of Oklahoma Health Sciences Center.
Translational Geroscience Laboratory, Reynolds Oklahoma Center on Aging, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center.
Division of Clinical Physiology, Faculty of Medicine, University of Debrecen, Hungary.

Tamas Kiss (T)

Vascular Cognitive Impairment and Neurodegeneration Program, Center for Geroscience, University of Oklahoma Health Sciences Center.

Aleksandra Perz (A)

Vascular Cognitive Impairment and Neurodegeneration Program, Center for Geroscience, University of Oklahoma Health Sciences Center.

Daniel O'Connor (D)

Vascular Cognitive Impairment and Neurodegeneration Program, Center for Geroscience, University of Oklahoma Health Sciences Center.

Emily Johnson (E)

Vascular Cognitive Impairment and Neurodegeneration Program, Center for Geroscience, University of Oklahoma Health Sciences Center.

Farzaneh Sorond (F)

Department of Neurology, Northwestern University, Chicago, Illinois.

Zoltan I Ungvari (ZI)

Vascular Cognitive Impairment and Neurodegeneration Program, Center for Geroscience, University of Oklahoma Health Sciences Center.
Translational Geroscience Laboratory, Reynolds Oklahoma Center on Aging, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center.
Department of Medical Physics and Informatics, Faculty of Medicine and Faculty of Science and Informatics, University of Szeged, Hungary.

Anna Csiszar (A)

Vascular Cognitive Impairment and Neurodegeneration Program, Center for Geroscience, University of Oklahoma Health Sciences Center.
Translational Geroscience Laboratory, Reynolds Oklahoma Center on Aging, Department of Geriatric Medicine, University of Oklahoma Health Sciences Center.
Department of Medical Physics and Informatics, Faculty of Medicine and Faculty of Science and Informatics, University of Szeged, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH